PUBLIC COMPANY
save$MISTMilestone Pharmaceuticals Inc.
$MISTMontreal, Quebec, CAupdated 13d ago
community read0 votes
pipeline
1
marketed
1
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
- phase2ReVeRA-201: Etripamil in Atrial Fibrillation, Phase 2
- phase3Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).
- phase3Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
Insider activity
source: SEC Form 4open-market buys + sells
- Apr 16, 26SELLOliveto Joseph· President and CEO−$82K↗
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that